Evidence map›Paper›PMID 25335695›Full record

ArticleThe Journal of antibiotics2015

Inhibition of biofilm formation in Bacillus subtilis by new halogenated furanones.

Airat R Kayumov, Elvina N Khakimullina, Irshad S Sharafutdinov, Elena Y Trizna, Lilia Z Latypova, Hoang Thi Lien, Anna B Margulis, Mikhail I Bogachev, Almira R Kurbangalieva

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in The Journal of antibiotics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. New BacteriophageViruses · 2025
    Article
  4. Article
  5. 3,4-Dihalo-5-hydroxy-2(5Molecules (Basel, Switzerland) · 2024
    Review
  6. The Antimicrobial Potential of the Hop (Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Titanium complexes affectRSC medicinal chemistry · 2023
    Article
  9. Alterations in Antibiotic Susceptibility ofInternational journal of molecular sciences · 2023
    Article
  10. The Novel Chiral 2(5Molecules (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Article
  13. Increasing the Efficacy of Treatment ofAntibiotics (Basel, Switzerland) · 2022
    Article
  14. Article
  15. The Bovhyaluronidase Azoximer (LongidazaMedicina (Kaunas, Lithuania) · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Airat R KayumovDepartment of Genetics, Kazan (Volga Region) Federal University, Kazan, Russia.
Elvina N KhakimullinaDepartment of Genetics, Kazan (Volga Region) Federal University, Kazan, Russia.
Irshad S SharafutdinovDepartment of Genetics, Kazan (Volga Region) Federal University, Kazan, Russia.
Elena Y TriznaDepartment of Genetics, Kazan (Volga Region) Federal University, Kazan, Russia.
Lilia Z LatypovaA.M. Butlerov Institute of Chemistry, Kazan (Volga Region) Federal University, Kazan, Russia.
Hoang Thi LienA.M. Butlerov Institute of Chemistry, Kazan (Volga Region) Federal University, Kazan, Russia.
Anna B MargulisDepartment of Genetics, Kazan (Volga Region) Federal University, Kazan, Russia.
Mikhail I BogachevBiomedical Engineering Research Center, St Petersburg State Electrotechnical University, St Petersburg, Russia.
Almira R KurbangalievaA.M. Butlerov Institute of Chemistry, Kazan (Volga Region) Federal University, Kazan, Russia.
Kazan Federal University · RUSaint Petersburg State Electrotechnical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gram-positive bacteria can cause various infections including hospital-acquired infections. While in the biofilm, the resistance of bacteria to both antibiotics and the human immune system is increased causing difficulties in the treatment. Bacillus subtilis, a non-pathogenic Gram-positive bacterium, is widely used as a model organism for studying biofilm formation. Here we investigated the effect of novel synthesized chloro- and bromo-containing 2(5H)-furanones on biofilm formation by B. subtilis. Mucobromic acid (3,4-dibromo-5-hydroxy-2(5H)-furanone) and the two derivatives of mucochloric acid (3,4-dichloro-5-hydroxy-2(5H)-furanone)-F8 and F12-were found to inhibit the growth and to efficiently prevent biofilm formation by B. subtilis. Along with the low production of polysaccharide matrix and repression of the eps operon, strong repression of biofilm-related yqxM also occurred in the presence of furanones. Therefore, our data confirm that furanones affect significantly the regulatory pathway(s) leading to biofilm formation. We propose that the global regulator, Spo0A, is one of the potential putative cellular targets for these compounds.

Indexed as

Anti-Bacterial AgentsBacillus subtilisBiofilmsFuransHydrocarbons, ChlorinatedMicrobial Sensitivity TestsMolecular Structure3,4-dichloro-5-((1,3-dichloropropan-2-yloxy))-2(5H)-furanone3-chloro-5-hydroxy-4-((4-methylphenylsulfanyl))-2(5H)-furanoneAnti-Bacterial AgentsFuransHydrocarbons, Chlorinatedmucobromic acid

Identifiers

PMID25335695
OpenAlexW2021744542

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.